Natural Cytotoxicity Triggering Receptor 2
"Natural Cytotoxicity Triggering Receptor 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 44-kD stimulatory receptor found on activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.
Descriptor ID |
D055629
|
MeSH Number(s) |
D12.776.543.750.705.895.750.200
|
Concept/Terms |
Natural Cytotoxicity Triggering Receptor 2- Natural Cytotoxicity Triggering Receptor 2
- NK-p44 Receptor
- NK p44 Receptor
- Receptor, NK-p44
- NKp44 Receptor
- Receptor, NKp44
- p44 Natural Killer Cell Receptor
- CD336 Antigen
- Antigen, CD336
- Antigens, CD336
- CD336 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Natural Cytotoxicity Triggering Receptor 2".
Below are MeSH descriptors whose meaning is more specific than "Natural Cytotoxicity Triggering Receptor 2".
This graph shows the total number of publications written about "Natural Cytotoxicity Triggering Receptor 2" by people in this website by year, and whether "Natural Cytotoxicity Triggering Receptor 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 0 | 2 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Natural Cytotoxicity Triggering Receptor 2" by people in Profiles.
-
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunol Res. 2019 07; 7(7):1120-1134.
-
Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46. J Gen Virol. 2018 06; 99(6):763-767.
-
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 2018 01 25; 172(3):534-548.e19.
-
The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection. PLoS One. 2017; 12(2):e0172625.